Ep. 260, Chapter 2: Navigating Life Sciences Policy with Jennifer Hawks Bland

7:59 – 12:45

Advocating for Merck and GSK, Bland faced complex legislative issues, including patent reform and the development of federal track-and-trace legislation for therapeutics. The latter initiative aimed to standardize serialization requirements across the supply chain, as individual states like California were creating disparate regulations. Bland emphasized the monumental effort involved in drafting and passing novel federal legislation, which requires years of collaboration across the industry, highlighting the power of collective action within the life sciences sector.